Stamford, CT -- (SBWIRE) -- 08/29/2013 -- High Rising Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Endeavour Silver Corp. (CAN) (NYSE:EXK), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Zale Corporation (NYSE:ZLC), First Majestic Silver Corp (NYSE:AG)
Endeavour Silver Corp. (CAN) (NYSE:EXK) shares decreased 4.67% to $4.90. The company on August 6 announced its financial results for the Second Quarter, 2013 (reported in US$). For the quarter ended June 30, 2013, the Company generated revenue totaling $71.1 million (2012 - $40.4 million). Adjusted loss was $2.7 million ($0.03 per share) compared to earnings of $5.9 million ($0.07 per share).
Should Investors Buy EXK After Yesterday’s Slump? Find Out Here
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) shares jumped 3.32% to $5.33. The company on August 22 announced the publication of the findings from the PRISM patient registry in PLOS ONE, an international, peer-reviewed, open-access medical journal. PRISM was the largest registry ever conducted to further understand prevalence and impact of pseudobulbar affect (PBA) in the United States.
Additionally, the company on August 12 said it reached an exclusive agreement to promote pharmaceutical giant Merck & Co.'s type-2 diabetes drug Januvia in long-term care institutional settings in the U.S. Under the accord, Avanir institutional sales force will begin promoting the sitagliptin family of products to health-care practitioners in the long-term care institutional setting in October.
Can Traders Buy AVNR After The Solid Rally? Get Free Trend Analysis Here
Zale Corporation (NYSE:ZLC) shares climbed 3.61% to $12.05. The company on August 28 reported its financial results for the fourth quarter and full year ended July 31, 2013. Revenues were $417 million compared to $407 million in the fourth quarter of fiscal 2012. Net loss was $8 million, or $0.25 per share, compared to a net loss of $20 million, or $0.61 per share, in the fourth quarter of fiscal 2012.
Should Investors Buy ZLC After Yesterday’s Slump? Find Out Here
First Majestic Silver Corp (NYSE:AG) stock decreased 4.16% to $13.84. Stock analysts at TD Securities upped their price objective on shares of First Majestic Silver from C$17.50 to C$18.00 in a report issued on August 14. The firm currently has a “buy” rating on the stock.
Additionally, the company released its earnings data on Tuesday, August 13th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.15 by $0.08. The company had revenue of $48.40 million for the quarter, compared to the consensus estimate of $90.13 million.
How Should Investors Trade AG After The Recent Volatility? Get Free Trend Analysis Here
High Rising Stocksis always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)